2025年10月29日，美国国土安全部宣布将华大基因、华大智造及深圳华大基因科技三家中国生物科技企业纳入“防止维吾尔人强迫劳动实体清单”1。随着此次新增，累计被列入该清单的中国企业总数已达190家1。根据美方机制，美国海关与边境保护局（CBP）将阻止上述企业的货物进入美国市场，除非出口商能够推翻相关强推定1。
针对美方的举措，中国商务部发言人表达了强烈谴责和坚决反对立场1。发言人指责美方做法是“打着人权的幌子行单边保护主义和霸凌主义之实”，并称此举严重破坏了中美经贸关系的稳定1。中方明确表示，对于美方这种“不知悔改”的行为，将采取必要措施以维护自身利益1。
The U.S. Department of Homeland Security announced on October 29, 2025, that three Chinese biotechnology companies have been added to the "Entity List to Prevent Forced Labor of Uyghurs" 1. The newly listed entities are BGI Genomics Co Ltd, MGI Tech Co Ltd, and Shenzhen BGI Technology Co Ltd 1. This expansion brings the total number of Chinese firms on the list to 190 1.
Under the mechanism operated by U.S. Customs and Border Protection (CBP), goods produced by these entities are barred from entering the United States unless exporters can rebut the presumption that they were made using forced labor 1. In response, a spokesperson for China’s Ministry of Commerce expressed strong condemnation and firm opposition to the move 1. The ministry accused Washington of acting with "unrepentant" persistence and using human rights as a pretext for unilateral protectionism and bullying 1. Beijing stated that these actions seriously undermine the stability of China-U.S. economic and trade relations and affirmed that it will take necessary measures to protect its own interests 1.
评论
还没有评论，欢迎留下第一条。